title: Reply: elevated serum fibrinogen: an independent link between diabetes mellitus, impaired on-clopidogrel platelet inhibition, and major adverse cardiac events after percutaneous coronary intervention.
authors.forename: Dominick J
authors.initials: DJ
authors.lastname: Angiolillo
authors.forename: Joseph A
authors.initials: JA
authors.lastname: Jakubowski
authors.forename: Francesco
authors.initials: F
authors.lastname: Franchi
authors.forename: Fabiana
authors.initials: F
authors.lastname: Rollini
authors.forename: Theodore A
authors.initials: TA
authors.lastname: Bass
mesh_terms: D003324:Coronary Artery Disease / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects*; D058921:Purinergic P2Y Receptor Antagonists / Q000627:therapeutic use*; D013988:Ticlopidine / Q000031:analogs & derivatives*
chemical_list: D058921:Purinergic P2Y Receptor Antagonists; D013988:Ticlopidine